Company Search:
Advanced Search
Sponsored Links
Tigenix Nv Company Snapshot
Tigenix Nv operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Tigenix Nv with three other companies in this sector in Belgium: Thrombogenics Nv (2016 sales of 7.10 million Euro [US$8.67 million] of which 100% was Royalty Income), MDxHealth S.A. (27.15 million Euro [US$33.15 million] of which 100% was Diagnostic Tools), and argenx NV (14.71 million Euro [US$17.96 million] of which 62% was License Fees).

Sales Analysis. Sales increased substantially in 2016: Tigenix Nv reported sales of 25.40 million Euro (US$31.01 million) for the year ending December of 2016. This represents an increase of 4,629.1% versus 2015, when the company's sales were 537,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Tigenix Nv
  Stock Performance Chart for Tigenix Nv
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 1.76
(Figures in Euro)
1 Week -0.2%   13 Weeks 2.3%  
4 Weeks 2.1%   52 Weeks 134.4%  
Tigenix Nv Key Data:
  Ticker: TIG Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 25,395,000
(Year Ending Jan 2017).
Employees: 89
  Currency: Euro Market Cap: 481,648,306
  Fiscal Yr Ends: December Shares Outstanding: 274,287,190
  Share Type: Parts Socials Closely Held Shares: 84,469,979
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.